Valbiotis SA
PAR:ALVAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valbiotis SA
PAR:ALVAL
|
FR |
|
Forty Pillars Mining Corp
F:69D
|
CA |
|
V
|
Varex Imaging Corp
F:VI4
|
US |
|
F
|
Federal National Mortgage Association
SWB:FNM
|
US |
|
W
|
Wooyang HC Co Ltd
KOSDAQ:101970
|
KR |
|
E
|
Essilorluxottica SA
F:ESLC
|
FR |
|
W
|
Wave Entertainment PCL
SET:WAVE
|
TH |
Intrinsic Value
Is ALVAL undervalued or overvalued?
See the intrinsic value estimate for Valbiotis SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ALVAL looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ALVAL’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Valbiotis Does
Valbiotis is a French health-science company that develops plant-based ingredients and finished products aimed at helping people manage metabolic health. Its work focuses on areas such as blood sugar control, cholesterol, weight management, and related wellness needs. Rather than selling a broad range of consumer brands, the company builds patented formulations and then turns them into ingredients or product concepts that can be used in supplements and nutrition products.
- Headquarters
- France FR
- Employees
- 41
- IPO date
- Jun 7, 2017
Earnings Waterfall
Valbiotis SA
The intrinsic value for Valbiotis SA (ALVAL) under the Base Case is hidden EUR.
Compared with the current market price of 0.524 EUR, the stock appears hidden.